MedCity Executive Chair Dr Eliot Forster has been announced as the new chief executive officer of Immunocore, a leading Oxford-based biotech company focused on the discovery and development of novel cancer therapies.
Forster, who will continue to lead MedCity, takes up the role at Immunocore after four years at Creabilis, a company developing treatments for skin disorders.
“This is a fantastic time to be part of the UK’s life sciences ecosystem, which is in a sustained period of ambition and creativity,” said Forster, adding “Immunocore is a really exciting company deservedly attracting international attention for its novel technologies addressing cancer and viral disease, and I’m delighted to be joining the team.”
